Sign up to save your podcasts
Or
Share Why GLP-1s like Ozempic and Wegovy could become "everything drugs"
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
![[Migrated] [PodTubeMe has migrated to a new system]](https://podcast-api-images.s3.amazonaws.com/corona/show/6322165/logo_300x300.png){kind=logo}
Why GLP-1s like Ozempic and Wegovy could become "everything drugs"
The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for patients and insurers.
THE BIG PICTURE: Blockbuster treatments like Ozempic have been found to lower the risk of everything from Alzheimer's and addiction, to sleep apnea, seizures and bacterial infections. More potential uses keep surfacing.
While it may be tempting to think of them as wonder drugs, there's a lot that's still unknown. It's still not clear whether they're a cure-all, or whether the benefits come from the fact that obesity and diabetes give rise to so many other health problems.
At over $1,000 a month, GLP-1s are also driving up costs in the health system, and their benefits can go away if patients discontinue the medications.
--
Support podtube.me continuity as a free service. Become a Patreon or make an one-time donation
--
Video at Youtube: https://www.youtube.com/watch?v=y-W0wgALdQ8
View all episodes
By [PodTubeMe has migrated to a new system]The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for patients and insurers.
THE BIG PICTURE: Blockbuster treatments like Ozempic have been found to lower the risk of everything from Alzheimer's and addiction, to sleep apnea, seizures and bacterial infections. More potential uses keep surfacing.
While it may be tempting to think of them as wonder drugs, there's a lot that's still unknown. It's still not clear whether they're a cure-all, or whether the benefits come from the fact that obesity and diabetes give rise to so many other health problems.
At over $1,000 a month, GLP-1s are also driving up costs in the health system, and their benefits can go away if patients discontinue the medications.
--
Support podtube.me continuity as a free service. Become a Patreon or make an one-time donation
--
Video at Youtube: https://www.youtube.com/watch?v=y-W0wgALdQ8